C19 steroids estrogenic activity in human breast cancer cell lines: Importance of dehydroepiandrosterone sulfate at physiological plasma concentration

Steroids

Volumn 63, Issue 12, 1998, Pages 678-683

  Le Bail, J Christophe ^a   Marre Fournier, Françoise ^a   Nicolas, J Claude ^b   Habrioux, Gérard ^a  

^a UPRES EA 1085   (France)

^b INSERM   (France)

Author keywords

C19 steroids; DHEAS; Estradiol; Luciferase activity; MCF 7 cells

Indexed keywords

11BETA HYDROXYANDROSTENEDIONE; AMINOGLUTETHIMIDE; ANDROSTANOLONE; ANDROSTENEDIOL; ESTRADIOL; ESTROGEN; LUCIFERASE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; HUMAN; HUMAN CELL; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CELL CULTURE; ENZYMOLOGY; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE; ESTROGENS; HUMANS; LUCIFERASES; TUMOR CELLS, CULTURED;

EID: 0032217322     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00078-6     Document Type: Article

References (46)

1. Rademaker B., Vossenberg J.B.J., Poortman J., Thijssen J.H.H. Metabolism of estradiol-17β, 5-androstene-3β,17β-diol and testosterone in human breast cancer cells in long term culture. J Steroid Biochem. 13:1979;787-791.
2. Lippman M., Balan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture. Cancer Res. 36:1976;4595-4609.
3. Najid A., Habrioux G. Biological effects of adrenal androgens on MCF-7 and BT 20 human breast cancer. Oncology. 47:1990;269-274.
4. Kitawaki J.O., Fukuoka M., Yamamoto T., Honjo H., Okada H. Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J Steroid Biochem Mol Biol. 42:1992;267-277.
5. MacIndoe J.H. Estradiol formation from testosterone by continuously cultured human breast cancer cells. J Clin Endocrinol Metab. 49:1979;272-277.
6. Zava D.T., MacGuire W.L. Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology. 103:1978;624-631.
7. Abul-Hajj Y.J. Metabolism of dehydroepiandrosterone by hormone dependent and hormone independent human breast cancer carcinoma. Steroids. 26:1975;488-500.
8. Adams J.B., Archibald L., Seymour Munn K. Dehydroepiandrosterone and androst-5-ene-3β,17β-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor. Cancer Res. 40:1980;3815-3820.
9. Adams J., Garcia M., Rochefort H. Estrogenic effects of physiological concentrations of 5-androstene-3β,17β-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Res. 41:1981;4720-4726.
10. Perel E., Daniilescu D., Kharpil L., Blaschstain M., Killinger D.W. Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J Steroid Biochem. 29:1988;393-399.
11. Poortman J., Prenen J.A.C., Scwarz F., Thijssen J.H.H. Interaction of 5-androstene-3β,17β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J Clin Endocrinol Metab. 40:1975;373-379.
12. Li K., Foo T., Adams J.B. Products of dehydroepiandrosterone metabolism by human mammary tumors and their influence on estradiol receptor binding. Steroids. 31:1978;113-127.
13. MacIndoe J.H., Etre L.A. Androgens inhibit estrogen action in MCF-7 human breast cancer cells. Life Sci. 27:1980;1643-1648.
14. MacIndoe J.H., Etre L.A. An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab. 53:1981;836-841.
15. Hackenberg R., Turgetto I., Filmer A., Schulz K.D. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β,17β-diol in human mammary cancer cells. J Steroid Biochem Mol Biol. 46:1993;597-603.
16. Kreitmann B., Bayard F. Androgen interaction with estrogen receptor in human tissues. J Steroid Biochem. 11:1979;1589-1595.
17. Boccuzzi G., Brignardello E., Di Monaco M., Forte C., Leonardi L., Pizzini A. Influence of dehydroepiandrosterone and 5-En-androstene-3β,17β-diol on the growth of MCF-7 human breast cancer cells induced by 17β-estradiol. Anticancer Res. 12:1992;799-804.
18. Pasqualini J.R., Gelly C., Nguyen B.L., Vella C. Importance of estrogen sulfates in breast cancer. J Steroid Biochem. 34:1989;155-163.
19. Le Bail J.C., Allen K., Nicolas J.C., Habrioux G. Dehydroepiandrosterone sulfate estrogenic action at physiological plasma concentration in human breast cancer cell lines. Anticancer Res. 18:1998;1683-1688.
20. Leblhuer F., Windhager E., Steinparz F.X., Dienstl E., Reiseker F., Rittmannsberger H. Dehydroepiandrosterone-sulfate (DHEAS) serum levels in normal aging and Alzeimer's disease (AD). Age. 14:1991;116-118.
21. Legrain S., Berr C., Frenoy N., Gourlet V., Debuire B., Baulieu E.E. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology. 41:1995;343-351.
22. Orentreich N., Brind J.L., Vogelman J.H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 75:1992;1002-1004.
23. Ravaglia G., Forti P., Maioli F., Bosschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an italian study on healthy free-living over-ninety-years-olds. J Clin Endocrinol Metab. 81:1996;1173-1178.
24. Dowsett M., Macaulay V., Oledhill J., Ryde C., Nicholls J., Asworth A., Kinna M.C., Smith I.E. Control of aromatase in breast cancer cells and its importance for tumor growth. J Steroid Biochem Mol Biol. 44:1993;605-609.
25. Tada A., Sasaki H., Nakamura J., Yoshihama M., Terashima Y. Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines. J Steroid Biochem Mol Biol. 44:1993;661-666.
26. Macaulay V.M., Nicholls J.E., Gledhill J., Rowlands M.G., Dowsett M., Ashworth A. Biological effect of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer. 69:1994;77-83.
27. Pons M., Gagne D., Nicolas J.C., Mehtali N. A new cellular model of response to estrogens A bioluminescent test to characterize (Anti) estrogen molecules . Biotechniques. 9:1990;450-459.
28. Joyeux A., Balaguer P., Germain P., Boussioux A.M., Pons M., Nicolas J.C. Engineered cell lines as a tool for monitoring biological activity of hormone analogs. Anal Biochem. 249:1997;119-130.
29. Metzger D., Berry M., Ali S., Chambon P. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol. 9:1995;579-591.
30. Green S., Issemann I., Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucl Acids Res. 16:1998;369-372.
31. Gagne D., Balager P., Demirpence E., Chabret C., Trousse F., Nicolas J.C., Pons M. Stable transfectant cells for studying steroid receptor biological activity. J Biolum Chem. 9:1994;201-209.
32. Bradford M. A rapid and sensitive method for the quantification of microgramme quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:1976;248-254.
33. Pasqualini J.R., Nguyen B. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone dependent vs. independent human breast cancer cell lines. Breast Cancer Res Treat. 18:1991;93-98.
34. Mainwaring W.I.P. A soluble androgen receptor in the cytoplasm of rat prostate. J Endocr. 45:1969;531-537.
35. Rochefort H., Garcia M. The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmac Ther. 23:1984;193-216.
36. Dowsett M., Lee K., Macaulay V.M., Detre S., Rowlands M., Grimshaw R. The control and biological importance of intratumoral aromatase in breast cancer. J Steroid Biochem Mol Biol. 56:1996;145-150.
37. Yue W., Wang J., Savinov A., Brodie A. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model. Cancer Res. 55:1995;3073-3077.
38. MacDonald P.C., Edman C.D., Kerber I.J., Siiteri P.K. Plasma precursors of estrogen III conversion of plasma dehydroepiandrosterone to estrogen in young nonpregnant women. Gynecol Invest. 35:1976;165-175.
39. Pizzini A., Brignardello E., Leonardi L., Di Monaco M., Boccuzzi G. Aromatase fails to mediate the proliferative effects of adrenal androgens on cultured MCF-7 breast cancer cells. Inter J Oncol. 1:1992;709-712.
40. Zhou D., Wang J., Chen E., Murai J., Siiteri P.K., Chen S. Aromatase gene is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol. 46:1993;147-153.
41. Poulin R., Labrie F. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res. 46:1986;4933-4937.
42. Montalto J., Funder J.W., Yong A.B., Callan A., Davies H.E., Connely J.F. Serum C-19 steroid sulphates in females with clinical hyperandrogenism. J Steroid Biochem. 34:1989;531-534.
43. Giagulli V.A., Giorgino R., Vermeulen A. Is plasma 5α-androstane-3α,17β-diol glucuronide a biochemical marker of hirsutism in women? J Steroid Biochem Mol Biol. 39:1991;55-61.
44. 19 steroid glucuronides in primates, rodents, and domestic animals. Am J Physiol. 271:1996;348-353.
45. Pasqualini J.R. Role of androgens in breast cancer. J Steroid Biochem Mol Biol. 45:1993;167-172.
46. Habrioux G., Desfosses B., Ventura G., Aron-Brunetiere R. Mesure des sulfoconjugués de 5-androstene-3β,17β-diol dans le virilisme pilaire idiopathique. Ann Endocrinol. 45:1984;143-148.